Diabetes Mellitus, Type 2: all 9,589 studies
Page 93 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and AsthmaTerminatedNCT00332826Phase 3
- Pilot Trial of Chromium-Metformin Combination in Type 2 DiabetesTerminatedNCT00332085Phase 1
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00331851Phase 3
- Safety and Efficacy of Inhaled Insulin in Type 2 DiabetesTerminatedNCT00331604Phase 3
- Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCompletedNCT00331487Phase 3
- A Concordance Study Comparing Insulin Treatments in Patients With Type 2 DiabetesCompletedNCT00330473Phase 3
- Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior TreatmentCompletedNCT00330330Phase 2
- Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 DiabeticsTerminatedNCT00330200Phase 2
- Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On InsulinCompletedNCT00329225Phase 4
- Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In KoreaCompletedNCT00328965Phase 4
- Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes MellitusCompletedNCT00328536Phase 4
- Effect of Pioglitazone on Ambulatory Blood PressureCompletedNCT00328393Phase 3
- Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With SulfonylureaWithdrawnNCT00327626Phase 2
- Patients With Heart Failure ANd Type 2 Diabetes Treated With Placebo Or Metformin (PHANTOM) Pilot StudyTerminatedNCT00325910Phase 3
- Long-Term Safety Study of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00325429Phase 3
- Study of Human Insulin Inhalation Powder in Patients With Type 2 DiabetesCompletedNCT00325364Phase 3
- To Assess the Efficacy and Safety of Vildagliptin as Add-on Therapy to Sulfonylurea in Patients With Type 2 Diabetes Inadequately Controlled With Sulfonylurea MonotherapyCompletedNCT00325117Phase 3
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and MetforminCompletedNCT00324363Phase 3
- A Study to Evaluate the Effect of Vitamin D Supplementation on Insulin Sensitivity and SecretionCompletedNCT00320853Not applicable
- Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and MicroalbuminuriaActive, not recruitingNCT00320008Not applicable
- Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 DiabetesCompletedNCT00318786Phase 3
- Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00318422Phase 3
- A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 DiabetesStatus unknownNCT00318032Not applicable
- Irbesartan in Type 2 DiabetesCompletedNCT00317915Phase 3
- A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.CompletedNCT00316758Phase 2
- Health2006 - an Observational Study of Cardiovascular Disease, Diabetes, Asthma and AllergyCompletedNCT00316667
- Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)CompletedNCT00315718Phase 3
- Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.CompletedNCT00313001Phase 3
- Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT00311818Phase 4
- Insulin Glulisine in Type 2 Diabetes MellitusCompletedNCT00310297Phase 1
- Diabetes and Combined Lipid Therapy Regimen (DIACOR) StudyCompletedNCT00309712Not applicable
- Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With NephropathyCompletedNCT00309127Not applicable
- A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DMCompletedNCT00308451Not applicable
- Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes MellitusCompletedNCT00308373Not applicable
- A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)CompletedNCT00308347Phase 3
- Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 DiabetesCompletedNCT00306644Phase 4
- Rosiglitazone and Exercise in Patients With Type 2 Diabetes MellitusCompletedNCT00306176Phase 4
- Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes MellitusCompletedNCT00304603
- Treatment of Patients With Type 2 Diabetes With an Interleukin-1 AntagonistCompletedNCT00303394Phase 2
- A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes MellitusCompletedNCT00302224Phase 1/2
- The Japan Diabetes Optimal Integrated Treatment Study for 3 Major Risk Factors of Cardiovascular DiseasesStatus unknownNCT00300976Not applicable
- Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular DysfunctionCompletedNCT00300911Phase 4
- A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild HyperglycemiaCompletedNCT00300287Phase 3
- GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 DiabetesTerminatedNCT00300105Phase 3
- Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes MellitusCompletedNCT00299871Phase 2
- Prevalence of Macrovascular Disease in Type 2 Diabetes MellitusStatus unknownNCT00298844
- BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-CompletedNCT00297063Phase 3
- GSK189075, GW869682 Or Placebo In Type 2 Diabetic PatientsCompletedNCT00291356Phase 2
- Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917CompletedNCT00290940Phase 2
- Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes MellitusCompletedNCT00290927Phase 3
- Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic PatientsCompletedNCT00290394Phase 4
- Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DMCompletedNCT00289354Not applicable
- Lifestyle Intervention in a General Population for Prevention of Ischaemic Heart DiseaseCompletedNCT00289237Not applicable
- Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)CompletedNCT00288236Phase 3
- The Diabetes TeleCare StudyCompletedNCT00288132Not applicable
- Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using InsulinCompletedNCT00287807Phase 3
- Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 DiabetesCompletedNCT00287404
- Long-term Mortality in Diabetics Undergoing Major SurgeryCompletedNCT00286572
- Moderate Alcohol Consumption, Risk of Cardiovascular Disease and Type 2 Diabetes: Influence of Alcohol OxidationCompletedNCT00285909Not applicable
- Rehabilitation of Type 2 Diabetes Patients.CompletedNCT00284609Not applicable
- Chromium and Insulin ActionCompletedNCT00283777Phase 4
- Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 DiabetesCompletedNCT00283751Phase 3
- Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or RosiglitazoneTerminatedNCT00282945Not applicable
- Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 DiabetesCompletedNCT00282451Phase 4
- Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart DiseaseCompletedNCT00282360Phase 4
- GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 DiabetesCompletedNCT00280865Phase 2
- Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00280046Phase 3
- Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideCompletedNCT00279045Phase 3
- Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled TrialCompletedNCT00277732Not applicable
- In-Home Weight Loss Program for Adults With Type 2 Diabetes Delivered by Interactive Cable Television TechnologyCompletedNCT00277277Not applicable
- Plant-Based Dietary Intervention in Type 2 DiabetesCompletedNCT00276939Not applicable
- Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 DiabetesCompletedNCT00274274Phase 4
- DETAIL Study: Diabetes Exposed to Telmisartan and EnalaprilCompletedNCT00274118Phase 3
- The Use of Cilostazol in Patients With Diabetic NephropathyCompletedNCT00272831Phase 4
- Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT00272077Phase 4
- ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.CompletedNCT00272064Phase 3
- OPAL - Insulin Glulisine, Diabetes MellitusCompletedNCT00272012Phase 3
- Omentectomy for the Treatment of Diabetes Mellitus Type 2CompletedNCT00270439Phase 1
- Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or InsulinCompletedNCT00269061Phase 1
- Insulin Glargine in Type 2 DiabetesCompletedNCT00268645Phase 4
- Physical Activity, Insulin Resistance and Function of Fat Tissue in the Offspring of Patients With Type 2 DiabetesCompletedNCT00268541Not applicable
- Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 DiabetesTerminatedNCT00267683Phase 3
- A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of MetforminCompletedNCT00266253Phase 2
- A Study of GK Activator (2) in Patients With Type 2 Diabetes MellitusCompletedNCT00266240Phase 2
- Prevention of Diabetes Mellitus Development in Women Who Had Already Experienced A Gestational DiabetesWithdrawnNCT00265746Phase 4
- Diagnosis of Insulin Resistance: 13C-Glucose Breath Test Vs HOMA Index.Status unknownNCT00264940
- Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 DiabetesCompletedNCT00264901Phase 4
- Exercise Training and Cardiovascular Function in Obesity and in Type 2 DiabetesCompletedNCT00264589Phase 4
- Cardiovascular Risk Factor Management in HIV InfectionCompletedNCT00264394Phase 4
- ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin SensitivityTerminatedNCT00263965Phase 2
- Stress-relief Management for Treatment of Late Complications in Type 2 DiabetesStatus unknownNCT00263419Not applicable
- A Trial of BMS-512148 in Patients With Type 2 Diabetes MellitusCompletedNCT00263276Phase 2
- C-Reactive Protein (CRP) in Obese Diabetic WomenCompletedNCT00262548Phase 4
- Dose Response Study in Japanese PatientsTerminatedNCT00261417Phase 2
- GALLANT 14 Tesaglitazar vs. Metformin and FenofibrateTerminatedNCT00261352Phase 3
- A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 DiabetesCompletedNCT00260156Phase 3
- In-patient Study in Patients With Type 2 Diabetes MellitusCompletedNCT00259896Phase 1
- Insulin Glargine During and After the Period of Fasting in RamadanCompletedNCT00258804Phase 4
- Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic PatientsCompletedNCT00257257Phase 3
- Markers and Mechanisms of Vascular Disease in Type II DiabetesCompletedNCT00256646